Lazaar Hamza, M. Sefrioui, T. Boutaj, Manal Tabchi, Boutayna Azarkan, Akkoumi Abdelkader, Saad Benchekroun, Abdellah Amazouzi, Lalla Ouafa Cherkaoui
{"title":"口服他达拉非后出现中心性浆液性脉络膜视网膜病变","authors":"Lazaar Hamza, M. Sefrioui, T. Boutaj, Manal Tabchi, Boutayna Azarkan, Akkoumi Abdelkader, Saad Benchekroun, Abdellah Amazouzi, Lalla Ouafa Cherkaoui","doi":"10.21474/ijar01/18317","DOIUrl":null,"url":null,"abstract":"Central serous chorioretinopathy (CSCR) is characterized by a localized serous detachment of the neuroretina (DSR), associated with detachments of the retinal pigment epithelium (RPE) at the posterior pole [1]and a leakage of fluid in the subretinal space. Pregnancy, Type A personality, and systemic corticosteroid therapy are the main risk factors for Central Serous Chorioretinopathy [ 2] We report the case of a patient who developed central serous chorioretinopathy following the oral intake of 20mg tadalafil erectile dysfunction, suggesting a possible involvement of phosphodiesterase type 5 inhibitors as a risk factor for central serous chorioretinopathy.","PeriodicalId":13781,"journal":{"name":"International Journal of Advanced Research","volume":"9 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CENTRAL SEROUS CHORIORETINOPATHY FOLLOWING ORAL USE OF TADALAFIL\",\"authors\":\"Lazaar Hamza, M. Sefrioui, T. Boutaj, Manal Tabchi, Boutayna Azarkan, Akkoumi Abdelkader, Saad Benchekroun, Abdellah Amazouzi, Lalla Ouafa Cherkaoui\",\"doi\":\"10.21474/ijar01/18317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Central serous chorioretinopathy (CSCR) is characterized by a localized serous detachment of the neuroretina (DSR), associated with detachments of the retinal pigment epithelium (RPE) at the posterior pole [1]and a leakage of fluid in the subretinal space. Pregnancy, Type A personality, and systemic corticosteroid therapy are the main risk factors for Central Serous Chorioretinopathy [ 2] We report the case of a patient who developed central serous chorioretinopathy following the oral intake of 20mg tadalafil erectile dysfunction, suggesting a possible involvement of phosphodiesterase type 5 inhibitors as a risk factor for central serous chorioretinopathy.\",\"PeriodicalId\":13781,\"journal\":{\"name\":\"International Journal of Advanced Research\",\"volume\":\"9 17\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Advanced Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21474/ijar01/18317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Advanced Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21474/ijar01/18317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
CENTRAL SEROUS CHORIORETINOPATHY FOLLOWING ORAL USE OF TADALAFIL
Central serous chorioretinopathy (CSCR) is characterized by a localized serous detachment of the neuroretina (DSR), associated with detachments of the retinal pigment epithelium (RPE) at the posterior pole [1]and a leakage of fluid in the subretinal space. Pregnancy, Type A personality, and systemic corticosteroid therapy are the main risk factors for Central Serous Chorioretinopathy [ 2] We report the case of a patient who developed central serous chorioretinopathy following the oral intake of 20mg tadalafil erectile dysfunction, suggesting a possible involvement of phosphodiesterase type 5 inhibitors as a risk factor for central serous chorioretinopathy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
